Tuesday, January 13, 2026
Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Home 2023 March

Monthly Archives: March 2023

Incubator

Smart for Life (SMFL) Reports Revenue Increases 96.9% to $17.8 Million...

Editor / Curator -
Marijuana Stock Review

Adding Vext Science (VEXTF) $0.17 to the Watch List.

Editor / Curator -
Incubator

Report: Think Equity Updates Society Pass (SOPA). $6.00 Price Target.

Editor / Curator -
Alternative Energy

IA Initiates Analyst Coverage of Principal Solar (Press Release).

Editor / Curator -
2020 Watch List

And We Have a $26.4 Billion Winning Trifecta!

Editor / Curator -
All News

Selling ARK (ARKK) & Buying AXS Short Innovation (SARK) ETF.

Editor / Curator -
2023 Watch List

Sanofi (SNY) to Acquire Provention Bio (PRVB) for $25 a Share....

Editor / Curator -
2022 Watch List

We’re Bearish, but we’re up 243% in Provention Bio (PRVB) Today.

Editor / Curator -
All News

Interview: Rokas Sidlauskas, Marketing Director of Society Pass (SOPA)

Editor / Curator -
Internet Stock Review, Biotech Stock Review, Roland Rick Perry
2023 Watch List

Unicycive Therapeutics (UNCY) $2.73 Tacks on Another 30%. We’re now up...

Editor / Curator -
12Page 1 of 2

Latest article

Y-Combinator | Top 10 Performing Portfolio Holdings

All News Editor / Curator -
Y Combinator, LLC (YC) is an US based technology startup accelerator and venture capital firm launched in March 2005, has incredibly been used to...

Society Pass (SOPA) Perking Up, Gains 169% in Last Trading Five Days.

2025 Watch List Editor / Curator -
For the record, we are not traders. And that 'not-something-moniker' dates back to 1995. So while it's nice to see it perking up, we...

Sekur Private Data (SKUR, SWISF) Inching Towards a Double!

Uncategorized Editor / Curator -
Sekur Private Data has been slowly working it's way higher, on a series of positive news events. Here are the headlines and short to...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.